Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
Hawaii Medical Journal
|
February 24, 2001
The Cancer Research Center of Hawaii University of Hawaii
C W Vogel
Targeted Diagnosis and Therapy
|
January 1, 1988
Synthesis of antibody conjugates with cobra venom factor using heterobifunctional cross-linking reagents
C W Vogel
Tropenmedizin Und Parasitologie
|
September 1, 1975
Spectrofluorometric and spectrodensitometric determination of chloroquine in plasma and urine
C W Vogel, E Königk
Molecular Immunology
|
June 1, 1989
The oligosaccharide chains of cobra venom factor are required for complement activation
A H Grier, C W Vogel
Journal of Immunological Methods
|
October 12, 1984
Cobra venom factor: improved method for purification and biochemical characterization
C W Vogel, H J Müller-Eberhard
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1981
Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase
C W Vogel, H J Müller-Eberhard
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1986
Immobilized doxorubicin increases the complement susceptibility of human melanoma cells by protecting complement component C3b against inactivation
M Panneerselvam, R Bredehorst, C W Vogel
FEBS Letters
|
March 1, 1979
A new cAMP affinity matrix for the rapid purification of protein kinase regulatory subunits
W Weber, C W Vogel, H Hilz
The Journal of Biological Chemistry
|
July 25, 1982
The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate
C W Vogel, H J Müller-Eberhard
Cancer Research
|
September 1, 1987
Resistance of human melanoma cells against the cytotoxic and complement-enhancing activities of doxorubicin
M Panneerselvam, R Bredehorst, C W Vogel
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
Hawaii Medical Journal
|
February 24, 2001
The Cancer Research Center of Hawaii University of Hawaii
C W Vogel
Targeted Diagnosis and Therapy
|
January 1, 1988
Synthesis of antibody conjugates with cobra venom factor using heterobifunctional cross-linking reagents
C W Vogel
Tropenmedizin Und Parasitologie
|
September 1, 1975
Spectrofluorometric and spectrodensitometric determination of chloroquine in plasma and urine
C W Vogel, E Königk
Molecular Immunology
|
June 1, 1989
The oligosaccharide chains of cobra venom factor are required for complement activation
A H Grier, C W Vogel
Journal of Immunological Methods
|
October 12, 1984
Cobra venom factor: improved method for purification and biochemical characterization
C W Vogel, H J Müller-Eberhard
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1981
Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase
C W Vogel, H J Müller-Eberhard
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1986
Immobilized doxorubicin increases the complement susceptibility of human melanoma cells by protecting complement component C3b against inactivation
M Panneerselvam, R Bredehorst, C W Vogel
FEBS Letters
|
March 1, 1979
A new cAMP affinity matrix for the rapid purification of protein kinase regulatory subunits
W Weber, C W Vogel, H Hilz
The Journal of Biological Chemistry
|
July 25, 1982
The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate
C W Vogel, H J Müller-Eberhard
Cancer Research
|
September 1, 1987
Resistance of human melanoma cells against the cytotoxic and complement-enhancing activities of doxorubicin
M Panneerselvam, R Bredehorst, C W Vogel
Page
of 7